[go: up one dir, main page]

TW200738719A - Organic compounds - Google Patents

Organic compounds

Info

Publication number
TW200738719A
TW200738719A TW096102341A TW96102341A TW200738719A TW 200738719 A TW200738719 A TW 200738719A TW 096102341 A TW096102341 A TW 096102341A TW 96102341 A TW96102341 A TW 96102341A TW 200738719 A TW200738719 A TW 200738719A
Authority
TW
Taiwan
Prior art keywords
phenyl
ethyl
piperazin
pyrrolo
pyrimidin
Prior art date
Application number
TW096102341A
Other languages
English (en)
Chinese (zh)
Inventor
Michael Mutz
Reto Fischer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37946476&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200738719(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TW200738719A publication Critical patent/TW200738719A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW096102341A 2006-01-23 2007-01-22 Organic compounds TW200738719A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76122406P 2006-01-23 2006-01-23

Publications (1)

Publication Number Publication Date
TW200738719A true TW200738719A (en) 2007-10-16

Family

ID=37946476

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096102341A TW200738719A (en) 2006-01-23 2007-01-22 Organic compounds

Country Status (13)

Country Link
EP (1) EP1979357A1 (ru)
JP (1) JP2009523768A (ru)
KR (1) KR20080095859A (ru)
CN (1) CN101370814A (ru)
AR (1) AR059090A1 (ru)
AU (1) AU2007206925A1 (ru)
BR (1) BRPI0706729A2 (ru)
CA (1) CA2636954A1 (ru)
PE (1) PE20071323A1 (ru)
RU (1) RU2008134314A (ru)
TN (1) TNSN08312A1 (ru)
TW (1) TW200738719A (ru)
WO (1) WO2007082946A1 (ru)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20011349A1 (es) * 2000-06-16 2002-01-19 Upjohn Co 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales
GB0119249D0 (en) * 2001-08-07 2001-10-03 Novartis Ag Organic compounds
AU2002349013A1 (en) * 2001-10-29 2003-05-12 Novartis Ag Use of 7h-pyrrolo(2,3-d)pyrimidine derivatives in the treatment of solid tumor diseases
US20080227980A1 (en) * 2005-08-05 2008-09-18 Novartis Ag Preparation of a 7H-Pyrrolo [2,3-D] Pyrimidine Derivative

Also Published As

Publication number Publication date
EP1979357A1 (en) 2008-10-15
AR059090A1 (es) 2008-03-12
PE20071323A1 (es) 2008-02-15
BRPI0706729A2 (pt) 2011-04-05
AU2007206925A1 (en) 2007-07-26
CN101370814A (zh) 2009-02-18
KR20080095859A (ko) 2008-10-29
TNSN08312A1 (en) 2009-12-29
WO2007082946A1 (en) 2007-07-26
JP2009523768A (ja) 2009-06-25
RU2008134314A (ru) 2010-02-27
CA2636954A1 (en) 2007-07-26

Similar Documents

Publication Publication Date Title
MX2009006700A (es) Derivados de 5-ciano-4-(pirolo)[2,3b]piridina-3-il)-pirimidinas utiles como inhibidores de proteina-cinasas.
WO2007120752A3 (en) 4, 5-dihydro- [1, 2, 4] triazolo [4, 3-f] pteridines as protein kinase plk1 inhibitors for the treatment of proliferative disorders
MX2010006748A (es) Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2.
MX337817B (es) Pirazolo [1,5-a] pirimidinas de utilidad como inhibidores de proteina quinasas.
WO2009087225A3 (en) Pyrrolopyrimidines and pyrrolopyridines
TW200633980A (en) Pyridones useful as inhibitors of kinases
MX2009009592A (es) Aminopiridinas utiles como inhibidores de proteinas cinasas.
WO2007095223A3 (en) Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases
WO2010011772A3 (en) Tri-cyclic pyrazolopyridine kinase inhibitors
MX2009008253A (es) Derivados de 2-aminopiridina utiles como inhibidores de cinasa.
MY150059A (en) Pyrrolo [2,3-d] pyrimidin derivatives as protein kinase b inhibitors
TW200613305A (en) Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
TNSN07165A1 (en) Organic compounds
WO2007095188A3 (en) Dihydrodiazepines useful as inhibitors of protein kinases
MX2009006345A (es) Compuestos utiles como inhibidores de proteina cinasa.
WO2007087283A3 (en) Thiophene-carboxamides useful as inhibitors of protein kinases
WO2007120760A3 (en) Thiophene-carboxamides useful as inhibitors of protein kinases
WO2007139816A3 (en) Thiophene-carboxamides useful as inhibitors of protein kinases
WO2008070313A3 (en) 3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
IL188942A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
MY150747A (en) Pyrido[2,3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
WO2007022384A3 (en) Pyrazine kinase inhibitors
NO20080418L (no) Pyrido[2,3-D]pyrimidiriderivater, fremgangsmate for fremstilling derav og terapeutisk anvendelse av samme
MX2009005231A (es) Composiciones utiles como inhibidores de proteina cinasa.
WO2009034547A3 (en) New 4-substituted derivatives of pyrazolo[3,4-d pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof